戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ium and is not present in M. tuberculosis or M. paratuberculosis.
2 the M. avium control has the DNA sequence of M. paratuberculosis.
3 ion of isolates of M. avium from isolates of M. paratuberculosis.
4 ty-six acid-fast isolates were identified as M. paratuberculosis, 15 were identified as belonging to
5 protein (hsp65) from 21 clinical isolates of M. paratuberculosis and 14 isolates of M. avium.
6 inguish between sheep and cattle isolates of M. paratuberculosis and easily and reproducibly differen
7 se drug susceptibility assay is reliable for M. paratuberculosis and gives results within 7 days, whe
8 apid differentiation of clinical isolates of M. paratuberculosis and M. avium.
9  M. avium-M. intracellulare complex (but not M. paratuberculosis), and the remaining 18 were identifi
10 cattle or humans, single-cell suspensions of M. paratuberculosis cells were adjusted to an optical de
11 udies requiring the quantification of viable M. paratuberculosis cells, such as drug susceptibility t
12 son with the previously described BACTEC 460 M. paratuberculosis counting method, quantification with
13  and AFLP genotypes (genotypes Z1 and Z2) of M. paratuberculosis described previously.
14                     None of the sera from 15 M. paratuberculosis-free cows, 3 Mycobacterium bovis BCG
15           We demonstrate the DNA sequence of M. paratuberculosis from mucosal specimens from humans w
16 de repeat sequences dispersed throughout the M. paratuberculosis genome, of which 78 were perfect rep
17                                Additionally, M. paratuberculosis has been linked to a human chronic g
18 previously constructed expression library of M. paratuberculosis in Escherichia coli.
19 d by exposure of PBMCs from clinical cows to M. paratuberculosis in vitro tended to be repression of
20 est up regulation following stimulation with M. paratuberculosis, including those encoding bovine CD4
21  similar (overall r = 0.84), suggesting that M. paratuberculosis-induced gene repression in clinicall
22 ost efficacious therapy for the treatment of M. paratuberculosis infections and that the use of fluor
23 avium) and M. avium subsp. paratuberculosis (M. paratuberculosis), intracellular bacteria that can ca
24 nd reproducible high-resolution subtyping of M. paratuberculosis isolates for molecular epidemiologic
25 ysis enables the genetic characterization of M. paratuberculosis isolates from different host species
26  nucleotide sequencing of the 78 loci of six M. paratuberculosis isolates from different host species
27 R) region enabled the differentiation of the M. paratuberculosis isolates in clade A18 into seven dis
28           The analysis differentiated the 33 M. paratuberculosis isolates into 20 distinct MLSSR type
29 loci was used to genotype a collection of 33 M. paratuberculosis isolates representing different mult
30                   The microorganism used was M. paratuberculosis K-10(pYUB180), a clinical isolate ca
31 rates the isolation and/or identification of M. paratuberculosis or a closely related M. avium comple
32 lly inoculated with multiple doses of viable M. paratuberculosis reacted with p35.
33 antibody reactivities by immunoblotting with M. paratuberculosis recombinant clones expressing the 36
34 e patients with ulcerative colitis contained M. paratuberculosis RNA.
35 ed characterization of a recently identified M. paratuberculosis short sequence repeat (SSR) region e
36                                     Although M. paratuberculosis signal in CD has been previously rep
37 Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis)-specific sequence (locus 251), and
38  were highly reproducible, regardless of the M. paratuberculosis strain or inoculum volume.
39 de evidence for the host specificity of some M. paratuberculosis strains as well as sharing of strain
40 S900 integration loci clustered 67 of the 76 M. paratuberculosis strains into a single clade (designa
41                               For each of 12 M. paratuberculosis strains isolated from either cattle
42 Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis) strains.
43  We employed reverse transcription PCR using M. paratuberculosis subspecies-specific primers (IS 900)
44  PBMCs from subclinically infected cows with M. paratuberculosis tended to up regulate expression of
45 Mycobacterium avium subsp. paratuberculosis (M. paratuberculosis), the causative agent of Johne's dis
46   We conclude that clinical trials with anti-M. paratuberculosis therapy are indicated in patients wi
47 obial agents with potential activity against M. paratuberculosis, we have developed a firefly lucifer

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。